Valturna FDA Approval History
FDA Approved: Yes (Discontinued) (First approved September 16, 2009)
Brand name: Valturna
Generic name: aliskiren and valsartan
Dosage form: Tablets
Company: Novartis Pharmaceuticals Corporation
Treatment for: High Blood Pressure
Marketing Status: Discontinued
Valturna is a combination of aliskiren (a direct renin inhibitor) and valsartan (an angiotensin II receptor blocker) indicated for the treatment of high blood pressure.
Development Timeline for Valturna
|Sep 17, 2009||Approval Novartis receives FDA approval for Valturna, a single-pill combination of valsartan and aliskiren, to treat high blood pressure|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.